Canopy Growth (CGC) Stock Price, News & Analysis

Company Overview

Canopy Growth Corporation is a cannabis company headquartered in Smiths Falls, Ontario, Canada. Founded in 2013, the company operates in the production, distribution and sale of cannabis and cannabis-related products for adult-use and medical markets.

Its product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes, beverages and edibles. Canopy Growth markets products under several brands, including Tweed, 7ACRES, Doja and Deep Space, with offerings designed for different consumer preferences and product segments.

Canopy Growth primarily serves the Canadian recreational and medical cannabis markets and has pursued international opportunities in selected medical-cannabis markets. Through its broader corporate strategy and affiliated interests, the company has also maintained exposure to cannabis-related businesses in the United States, where federal restrictions limit direct interstate cannabis commerce.

Key Stats

• Today's Range: $0.64 to $0.69
• 50-Day Range: $0.65 to $1.07
• 52-Week Range: $0.64 to $2.38
• Volume: 2.28 million shs
• Average Volume: 2.44 million shs
• Market Capitalization: $293.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Canopy Growth Stock Analysis - MarketRank™

Canopy Growth scored higher than 21% of companies evaluated by MarketBeat, and ranked 819th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Hold

Consensus Rating

Canopy Growth has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 2 buy ratings, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Canopy Growth has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Canopy Growth are expected to grow in the coming year, from ($0.10) to ($0.07) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Canopy Growth is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Canopy Growth is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Canopy Growth has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.07% of the float of Canopy Growth has been sold short.

Short Interest Ratio / Days to Cover

Canopy Growth has a short interest ratio ("days to cover") of 10.75, which indicates bearish sentiment.

Change versus previous month

Short interest in Canopy Growth has recently increased by 16.13%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Canopy Growth does not currently pay a dividend.

Dividend Growth

Canopy Growth does not have a long track record of dividend growth.

News and Social Media

• Score: 4.5 / 5
• News Sentiment: 1.23

News Sentiment

Canopy Growth has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Canopy Growth this week, compared to 6 articles on an average week.

Search Interest

7 people have searched for CGC on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.

MarketBeat Follows

7 people have added Canopy Growth to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Canopy Growth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $66,482.00 in company stock.

Percentage Held by Insiders

0.35% of the stock of Canopy Growth is held by insiders.

Percentage Held by Institutions

3.33% of the stock of Canopy Growth is held by institutions.

Company Calendar

• Last Earnings: 8/07/2026
• Today: 11/01/2026
• Next Earnings (Estimated): 11/06/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:CGC
• CIK: 1737927
• Web: www.canopygrowth.com
• Phone: (855) 558-9333
• Fax: N/A
• Employees: 1,128
• Year Founded: 2014

Profitability

• EPS (Trailing Twelve Months): ($0.45)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$190.29 million
• Net Margins: -65.33%
• Pretax Margin: -65.97%
• Return on Equity: -21.91%
• Return on Assets: -14.34%

Debt

• Debt-to-Equity Ratio: 0.31
• Current Ratio: 3.04
• Quick Ratio: 2.39

Sales & Book Value

• Annual Sales: $251.01 million
• Price / Sales: 1.17
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.13 per share
• Price / Book: 0.58

Miscellaneous

• Outstanding Shares: 449,300,000
• Free Float: 447,726,000
• Market Cap: $293.17 million
• Optionable: Optionable
• Beta: 0.78